SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lorus Therapeutics Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (30)3/22/1997 5:06:00 PM
From: ROY PHUNG   of 279
 
To all:

I e-mailed IMT last week and here is their latest comments

Date: Fri, 21 Mar 1997 16:10:34 -0800
From: "Wayne D. Cockburn" <imutec@inforamp.net>
Reply-To: imutec@inforamp.net
Organization: Imutec Pharma Inc.
To: kphung@cadvision.com
Subject: Your Email
X-UIDL: b38598f14bcd06ca8f65a3479624efe8

In fact, the average volume has been increasing, not decreasing. It is perfectly normal when for a share price to fall on low volumn. Our
shares are no different.

New brokers, in fact, have been buying the shares. We have more
shareholders now than we have ever had. I'm sorry that your confidence in the company is going down. Perhaps you need to evaluate your position in the company.

We have recently begun an active investor relation program which will
take us to every major city in Canada, several cities in Europe and some limited exposure in the United States. We agree that we need to udate people on our activities, and that is what we are doing.

The final clinical results will likely be available by the end of the
summer. We will be releasing the data by Press Release at that point.

If you would like a copy of some recent research reports on the company,
please send me your address.

Regards,

Wayne Cockburn
Vice President, Corporate Development
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext